CERINTA Drug Patent Profile
✉ Email this page to a colleague
When do Cerinta patents expire, and when can generic versions of Cerinta launch?
Cerinta is a drug marketed by Sun Pharm and is included in one NDA.
The generic ingredient in CERINTA is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CERINTA?
- What are the global sales for CERINTA?
- What is Average Wholesale Price for CERINTA?
Summary for CERINTA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CERINTA at DailyMed |
US Patents and Regulatory Information for CERINTA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm | CERINTA | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 202817-001 | Jan 7, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
